Search research articles
Contact Us
Filters
Showing results (201-210 of 337) with videos related to
Page
of 34
Sort By:
The Journal of Biological Chemistry
|
February 18, 2018
Structural and compositional diversity of fibrillin microfibrils in human tissues
Alexander Eckersley, Kieran T Mellody, Suzanne Pilkington, et al.
The Journal of Investigative Dermatology
|
May 13, 2026
A survey of patients attending the Regional Dermatology Training Centre, Moshi, Tanzania 2017-2020
Aakaash Varma, Lakshaajeni Thevapalan, Doriane Sabushimike, et al.
Journal of the American Academy of Dermatology
|
July 4, 2018
Ixekizumab provides superior efficacy compared with ustekinumab over 52 weeks of treatment: Results from IXORA-S, a phase 3 study
Carle Paul, Christopher E M Griffiths, Peter C M van de Kerkhof, et al.
The Journal of Investigative Dermatology
|
June 12, 2004
Divergent beliefs about psoriasis are associated with increased psychological distress
Helen L Richards, Dónal G Fortune, Stephanie L P Chong, et al.
Scientific Reports
|
December 15, 2022
Menopause induces changes to the stratum corneum ceramide profile, which are prevented by hormone replacement therapy
Alexandra C Kendall, Suzanne M Pilkington, Jonathan R Wray, et al.
The Gerontologist
|
March 20, 2016
Age-Associated Skin Conditions and Diseases: Current Perspectives and Future Options
Ulrike Blume-Peytavi, Jan Kottner, Wolfram Sterry, et al.
American Journal of Clinical Dermatology
|
March 31, 2018
Correction to: Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders: A Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque Psoriasis (UNCOVER-2 and -3)
Andrew Blauvelt, Kim A Papp, Christopher E M Griffiths, et al.
American Journal of Clinical Dermatology
|
January 12, 2017
Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders: A Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque Psoriasis (UNCOVER-2 and -3)
Andrew Blauvelt, Kim A Papp, Christopher E M Griffiths, et al.
Redox Biology
|
April 28, 2015
A potential role for endogenous proteins as sacrificial sunscreens and antioxidants in human tissues
Sarah A Hibbert, Rachel E B Watson, Neil K Gibbs, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
October 11, 2023
Implementing well-being in the management of psoriasis: An expert recommendation
Rachel Sommer, Ulrich Mrowietz, Kristian Gaarn Du Jardin, et al.
Page
of 34
Search research articles
Search
Showing results (201-210 of 337) with videos related to
Sort By:
Page
of 34
The Journal of Biological Chemistry
|
February 18, 2018
Structural and compositional diversity of fibrillin microfibrils in human tissues
Alexander Eckersley, Kieran T Mellody, Suzanne Pilkington, et al.
The Journal of Investigative Dermatology
|
May 13, 2026
A survey of patients attending the Regional Dermatology Training Centre, Moshi, Tanzania 2017-2020
Aakaash Varma, Lakshaajeni Thevapalan, Doriane Sabushimike, et al.
Journal of the American Academy of Dermatology
|
July 4, 2018
Ixekizumab provides superior efficacy compared with ustekinumab over 52 weeks of treatment: Results from IXORA-S, a phase 3 study
Carle Paul, Christopher E M Griffiths, Peter C M van de Kerkhof, et al.
The Journal of Investigative Dermatology
|
June 12, 2004
Divergent beliefs about psoriasis are associated with increased psychological distress
Helen L Richards, Dónal G Fortune, Stephanie L P Chong, et al.
Scientific Reports
|
December 15, 2022
Menopause induces changes to the stratum corneum ceramide profile, which are prevented by hormone replacement therapy
Alexandra C Kendall, Suzanne M Pilkington, Jonathan R Wray, et al.
The Gerontologist
|
March 20, 2016
Age-Associated Skin Conditions and Diseases: Current Perspectives and Future Options
Ulrike Blume-Peytavi, Jan Kottner, Wolfram Sterry, et al.
American Journal of Clinical Dermatology
|
March 31, 2018
Correction to: Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders: A Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque Psoriasis (UNCOVER-2 and -3)
Andrew Blauvelt, Kim A Papp, Christopher E M Griffiths, et al.
American Journal of Clinical Dermatology
|
January 12, 2017
Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders: A Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque Psoriasis (UNCOVER-2 and -3)
Andrew Blauvelt, Kim A Papp, Christopher E M Griffiths, et al.
Redox Biology
|
April 28, 2015
A potential role for endogenous proteins as sacrificial sunscreens and antioxidants in human tissues
Sarah A Hibbert, Rachel E B Watson, Neil K Gibbs, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
October 11, 2023
Implementing well-being in the management of psoriasis: An expert recommendation
Rachel Sommer, Ulrich Mrowietz, Kristian Gaarn Du Jardin, et al.
Page
of 34